Ten Largest Investments

Summary by AI ^BETAClose X

JPMorgan Global Emerging Markets Income Trust PLC announced its ten largest investments as of September 30, 2025. The largest holding is Taiwan Semiconductor Manufacturing Co Ltd, representing 8.8% of total assets, followed by Samsung Electronics Co Ltd at 5.2% and Tencent Holdings Ltd at 4.6%. Netease accounts for 2.7%, while Hdfc Bank Ltd represents 2.3%. Fuyao Glass Industry Group and Realtek both hold 2.2%. National Bank Of Greece accounts for 2.1%, Wal-Mart De Mexico for 1.9%, and Midea Group for 1.8%. Collectively, these top ten investments constitute 34.0% of the company's total assets, excluding investments in liquidity stocks.

Disclaimer*

JPMorgan Global Emerging Mkts I.T.

14 October 2025

JPMORGAN GLOBAL EMERGING MARKETS INCOME TRUST PLC (the 'Company')
Legal Entity Identifier: 549300OPJXU72JMCYU09
THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 30 September 2025
Taiwan Semiconductor Manufacturing Co Ltd	8.8%
Samsung Electronics Co Ltd	5.2%
Tencent Holdings Ltd	4.6%
Netease	2.7%
Hdfc Bank Ltd	2.3%
Fuyao Glass Industry Group	2.2%
Realtek	2.2%
National Bank Of Greece	2.1%
Wal-Mart De Mexico	1.9%
Midea Group	1.8%
Total	34.0%
Excludes Investments in Liquidity stocks
Name of contact and telephone number for queries:
Paul Ainger 0044 207 742 6524
Name of authorised company official responsible for making this notification:
Emma Lamb 020 7742 4000 - Company Secretary
Date: 14 October 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END